Kodiak Sciences (KOD) last raised capital by closing an underwritten public offering of common stock on December 18, 2025, which generated approximately $184 million in gross proceeds. Key Insights The offering included the full exercise of the underwriters' option to purchase additional shares, resulting in a total of 8 million shares sold at a price of $23.00 per share. The capital raise bolsters the company's financial position to fund its ongoing business operations and the development of its precommercial retina therapeutics pipeline.
They raised $184m ....they aren't disappearing any time soon JMO Kiwi